Finance and Economics APP notification, huapont life sciences (002004.SZ) released the third quarter report of 2024. In the first three quarters, the company achieved revenue of 8.91 billion yuan, a year-on-year increase of 0.64%. The net income attributable to shareholders of the listed company was 0.452 billion yuan, a year-on-year decrease of 10.49%. The net income attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 0.436 billion yuan, a year-on-year decrease of 9.78%.